PDF(2438 KB)
普列克底物蛋白同源物样结构域家族A成员1蛋白——导致代谢疾病的多方面细胞存活因素
Tamana Yousof, Jae Hyun Byun, Jack Chen, Richard C. Austin
工程（英文） ›› 2023, Vol. 20 ›› Issue (1) : 9-18.
PDF(2438 KB)
PDF(2438 KB)
普列克底物蛋白同源物样结构域家族A成员1蛋白——导致代谢疾病的多方面细胞存活因素
Pleckstrin Homology-Like Domain, Family A, Member 1 (PHLDA1): A Multifaceted Cell Survival Factor that Drives Metabolic Disease
普列克底物蛋白同源物样结构域家族A成员1（PHLDA1）是多作用的胞内蛋白，属于进化上保守的普列克底物蛋白同源相关结构域家族。最初，PHLDA1的小鼠同源基因——T 细胞死亡相关51 基因（TDAG51）——因其在T细胞杂交瘤中活化诱导的细胞凋亡中的作用而被发现。近年来，由于PHLDA与肥胖症、脂肪性肝病、糖尿病、动脉硬化和癌症有关，因此受到越来越多的关注。越来越多的证据也证实，PHLDA1在内质网应激信号通路中作为细胞凋亡、自噬和增殖的关键介质发挥作用。本文综述了PHLDA1基因及蛋白调控、定位和功能方面的现有知识。本文重点介绍了PHLDA1促凋亡和抗凋亡，进而导致代谢性疾病的作用。
Pleckstrin homology-like domain, family A, member 1 (PHLDA1) is a multifaceted intracellular protein belonging to the evolutionarily conserved pleckstrin homology-related domain family. Its murine homologue, T-cell death-associated 51 (TDAG51) gene, was initially discovered for its role in activation-induced apoptosis in T-cell hybridomas. In recent years, PHLDA1 has received increased attention due to its association with obesity, fatty liver disease, diabetes, atherosclerosis, and cancer. Accumulating evidence also supports its role in endoplasmic reticulum stress signaling pathways as a crucial mediator of apoptosis, autophagy, and cell proliferation. In this review, the current knowledge of PHLDA1 gene and protein regulation, localization, and function is summarized. This review highlights the pro- and anti-apoptotic roles of PHLDA1 that contribute to vast array of metabolic diseases.
内质网应激 / 代谢 / 凋亡 / 细胞存活 / 普列克底物蛋白同源物样结构域家族A成员1（PHLDA1）
ER-stress / Metabolism / Apoptosis / Cell survival / PHLDA1
| [1] |
Li Y, Teng D, Shi X, Qin G, Qin Y, Quan H, et al. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study. BMJ 2020;369:m997.
|
| [2] |
Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, et al. IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract 2018;138:271–81.
|
| [3] |
IDF. IDF Diabetes Atlas. 10th edition [Internet]. Brussels: IDF; 2021 Dec 6 [cited 2021 Dec 6]. Available from: https://diabetesatlas.org/en/resources/.
|
| [4] |
Einarson TR, Acs A, Ludwig C, Panton UH. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017. Cardiovasc Diabetol 2018;17(1):83.
|
| [5] |
Jia W, Weng J, Zhu D, Ji L, Lu J, Zhou Z, et al. CDS. Standards of medical care for type 2 diabetes in China 2019. Diabetes Metab Res Rev 2019;35(6):e3158.
|
| [6] |
Llavero-Valero M, Escalada San Martín J, Martínez-González MA, Alvarez-Mon MA, Alvarez-Alvarez I, Martínez-González J, et al. Promoting exercise, reducing sedentarism or both for diabetes prevention: the ‘‘Seguimiento Universidad De Navarra” (SUN) cohort. Nutr Metab Cardiovasc Dis 2021;31(2):411–9.
|
| [7] |
Patnode CD, Evans CV, Senger CA, Redmond N, Lin JS. Behavioral counseling to promote a healthful diet and physical activity for cardiovascular disease prevention in adults without known cardiovascular disease risk factors: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA 2017;318(2):175–93.
|
| [8] |
Boulé NG, Kenny GP, Haddad E, Wells GA, Sigal RJ. Meta-analysis of the effect of structured exercise training on cardiorespiratory fitness in type 2 diabetes mellitus. Diabetologia 2003;46(8):1071–81.
|
| [9] |
Balducci S, D’Errico V, Haxhi J, Sacchetti M, Orlando G, Cardelli P, et al. Level and correlates of physical activity and sedentary behavior in patients with type 2 diabetes: a cross-sectional analysis of the Italian Diabetes and Exercise Study_2. PLoS One 2017;12(3):e0173337.
|
| [10] |
Lear SA, Hu W, Rangarajan S, Gasevic D, Leong D, Iqbal R, et al. The effect of physical activity on mortality and cardiovascular disease in 130 000 people from 17 high-income, middle-income, and low-income countries: the PURE study. Lancet 2017;390(10113):2643–54.
|
| [11] |
Biswas A, Oh PI, Faulkner GE, Bajaj RR, Silver MA, Mitchell MS, et al. Sedentary time and its association with risk for disease incidence, mortality, and hospitalization in adults: a systematic review and meta-analysis. Ann Intern Med 2015;162(2):123–32.
|
| [12] |
Lamb MJE, Westgate K, Brage S, Ekelund U, Long GH, Griffin SJ, et al. Prospective associations between sedentary time, physical activity, fitness and cardiometabolic risk factors in people with type 2 diabetes. Diabetologia 2016;59(1):110–20.
|
| [13] |
Rossen J, Von Rosen P, Johansson UB, Brismar K, Hagströmer M. Associations of physical activity and sedentary behavior with cardiometabolic biomarkers in prediabetes and type 2 diabetes: a compositional data analysis. Phys Sportsmed 2020;48(2):222–8.
|
| [14] |
Rossen J, Buman MP, Johansson UB, Yngve A, Ainsworth B, Brismar K, et al. Reallocating bouted sedentary time to non-bouted sedentary time, light activity and moderate-vigorous physical activity in adults with prediabetes and type 2 diabetes. PLoS ONE 2017;12(7):e0181053.
|
| [15] |
Joseph JJ, Deedwania P, Acharya T, Aguilar D, Bhatt DL, Chyun DA, et al. Comprehensive management of cardiovascular risk factors for adults with type 2 diabetes: a scientific statement from the American Heart Association. Circulation 2022;145(9):e722–59.
|
| [16] |
Yao WY, Han MG, De Vito G, Fang H, Xia Q, Chen Y, et al. Physical activity and glycemic control status in Chinese patients with type 2 diabetes: a secondary analysis of a randomized controlled trial. Int J Environ Res Public Health 2021;18(8):4292.
|
| [17] |
Wang Y, Guan Q, Hou X, Zhang X, Zhang H, Xu C, et al. Multifactorial Intervention on Type 2 Diabetes (MIDiab) study: a multicenter, open-label, randomized, parallel controlled, community trial. J Diabetes 2020;12 (11):862–4.
|
| [18] |
Alberti KGMM, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15 (7):539–53.
|
| [19] |
Fan M, Lyu J, He P. Chinese guidelines for data processing and analysis concerning the International Physical Activity Questionnaire. Chin J Epidemiol 2014;35(8):961–4. Chinese.
|
| [20] |
Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth BE, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003;35(8):1381–95.
|
| [21] |
Bull FC, Al-Ansari SS, Biddle S, Borodulin K, Buman MP, Cardon G, et al. World Health Organization 2020 guidelines on physical activity and sedentary behaviour. Br J Sports Med 2020;54(24):1451–62.
|
| [22] |
Bames J, Behrens TK, Benden ME, Biddle S, Bond D, Brassard P, et al. Letter to the editor: standardized use of the terms ‘‘sedentary” and ‘‘sedentary behaviours”. Appl Physiol Nutr Metab 2012;37(3):540–2.
|
| [23] |
Haskell WL, Lee IM, Pate RR, Powell KE, Blair SN, Franklin BA, et al. Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc 2007;39(8):1423–34.
|
| [24] |
Sattelmair J, Pertman J, Ding EL, Kohl 3rd HW, Haskell W, Lee IM. Dose response between physical activity and risk of coronary heart disease: a metaanalysis. Circulation 2011;124(7):789–95.
|
| [25] |
Colberg SR, Albright AL, Blissmer BJ, Braun B, Chasan-Taber L, Fernhall B, et al. Exercise and type 2 diabetes: American College of Sports Medicine and the American Diabetes Association: joint position statement. Exercise and type 2 diabetes. Med Sci Sports Exerc 2010;42(12):2282–303.
|
| [26] |
Buse JB, Ginsberg HN, Bakris GL, Clark NG, Costa F, Eckel R, et al. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation 2007;115(1):114–26.
|
| [27] |
Hamasaki H. Daily physical activity and type 2 diabetes: a review. World J Diabetes 2016;7(12):243–51.
|
| [28] |
Chodzko-Zajko WJ, Proctor DN, Fiatarone Singh MA, Minson CT, Nigg CR, Salem GJ, et al.; American College of Sports Medicine Position Stand. Exercise and physical activity for older adults. Med Sci Sports Exerc 2009;41 (7):1510–30.
|
| [29] |
Gillespie LD, Robertson MC, Gillespie WJ, Sherrington C, Gates S, Clemson LM, et al. Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev 2012(9):CD007146.
|
| [30] |
Colberg SR, Sigal RJ, Yardley JE, Riddell MC, Dunstan DW, Dempsey PC, et al. Physical activity/exercise and diabetes: a position statement of the American Diabetes Association. Diabetes Care 2016;39(11):2065–79.
|
| [31] |
Ekelund U, Brown WJ, Steene-Johannessen J, Fagerland MW, Owen N, Powell KE, et al. Do the associations of sedentary behaviour with cardiovascular disease mortality and cancer mortality differ by physical activity level? A systematic review and harmonised meta-analysis of data from 850 060 participants. Br J Sports Med 2019;53(14):886–94.
|
| [32] |
Carter S, Hartman Y, Holder S, Thijssen DH, Hopkins ND. Sedentary behavior and cardiovascular disease risk: mediating mechanisms. Exerc Sport Sci Rev 2017;45(2):80–6.
|
| [33] |
Paz-Krumdiek M, Rodriguez-Vélez SG, Mayta-Tristán P, Bernabe-Ortiz A. Association between sitting time and obesity: a population-based study in Peru. Nutr Diet 2020;77(2):189–95.
|
| [34] |
Kachur S, Lavie CJ, de Schutter A, Milani RV, Ventura HO. Obesity and cardiovascular diseases. Minerva Med 2017;108(3):212–28.
|
| [35] |
Durrer C, Francois M, Neudorf H, Little JP. Acute high-intensity interval exercise reduces human monocyte Toll-like receptor 2 expression in type 2 diabetes. Am J Physiol Regul Integr Comp Physiol 2017;312(4):R529–38.
|
| [36] |
Healy GN, Dunstan DW, Salmon J, Cerin E, Shaw JE, Zimmet PZ, et al. Breaks in sedentary time: beneficial associations with metabolic risk. Diabetes Care 2008;31(4):661–6.
|
| [37] |
Benatti FB, Ried-Larsen M. The effects of breaking up prolonged sitting time: a review of experimental studies. Med Sci Sports Exerc 2015;47 (10):2053–61.
|
| [38] |
Jarvie JL, Pandey A, Ayers CR, McGavock JM, Sénéchal M, Berry JD, et al. Aerobic fitness and adherence to guideline-recommended minimum physical activity among ambulatory patients with type 2 diabetes mellitus. Diabetes Care 2019;42(7):1333–9.
|
| [39] |
Archundia Herrera MC, Subhan FB, Chan CB. Dietary patterns and cardiovascular disease risk in people with type 2 diabetes. Curr Obes Rep 2017;6(4):405–13.
|
| [40] |
Holtermann A, Schnohr P, Nordestgaard BG, Marott JL. The physical activity paradox in cardiovascular disease and all-cause mortality: the contemporary Copenhagen General Population Study with 104 046 adults. Eur Heart J 2021;42(15):1499–511.
|
/
| 〈 |
|
〉 |
